Table 3.
Aβ | Aβ + AβN3pE | Aβ + AβN3pE + AβpSer8 | AβN3pE + AβpSer8 | AβpSer8 | AβN3pE | |
---|---|---|---|---|---|---|
Soluble fraction | 50% (n = 4) | 25% (n = 2) | 25% (n = 2) | 0% (n = 0) | 0% (n = 0) | 0% (n = 0) |
Dispersible fraction | 20.8% (n = 5) | 29.2% (n = 7) | 50% (n = 12) | 0% (n = 0) | 0% (n = 0) | 0% (n = 0) |
Total fraction | 62.5% (n = 5) | 12.5% (n = 1) | 25% (n = 2) | 0% (n = 0) | 0% (n = 0) | 0% (n = 0) |
Values with a positive percentage between 50 and 74% are highlighted in bold. The table indicates the percentages of mice with seeded Aβ lesions exhibiting all three types of Aβ (Aβ, AβN3pE and AβpSer8), Aβ lesions lacking AβN3pE and AβpSer8, and Aβ lesions showing only Aβ and AβN3pE but no AβpSer8. We did not observe AβN3pE and AβpSer8 in the absence of non-modified Aβ and AβpSer8 without coexisting Aβ and AβN3pE. It is interesting to note that injection of the dispersible fraction induced more frequently the induction of all types of Aβ species whereas injection of the soluble and total fraction led mainly to the induction Aβ lacking AβN3pE and AβpSer8.